Robert Martell - Jan 29, 2022 Form 4 Insider Report for CURIS INC (CRIS)

Role
Head of Research & Development
Signature
William Steinkrauss, attorney-in-fact
Stock symbol
CRIS
Transactions as of
Jan 29, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 04:16 PM
Next filing
Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRIS Employee stock option (right to buy) Award $0 +252K $0.00 252K Jan 29, 2022 Common stock 252K $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.